Optimizing Linezolid: Transforming It into a Selective MAO-B Inhibitor via a Toxicity-to-Activity Optimization Approach.
Dhangar MS, Ahmad I, Oh JM, Patil BR, Chinnam S, Sriram D, Kumari J, Mathew B, Sayyed RA, Chaudhari SB, Ansari SA, Rai N, Kim H, Patel HM.
Dhangar MS, et al. Among authors: kumari j.
ACS Med Chem Lett. 2024 Dec 16;16(1):40-50. doi: 10.1021/acsmedchemlett.4c00354. eCollection 2025 Jan 9.
ACS Med Chem Lett. 2024.
PMID: 39811132